Insider buying last 90 days
No open-market insider purchases were filed for RYAN in the last 90 days.
From Form 4 filings, dated to when each was filed.
Nov 13 close
Ryan Specialty's recent move ties to an analysis piece highlighting institutional trading strategies around RYAN, which pointed to strong near and mid-term sentiment, a weak long-term outlook, and what it described as an ongoing breakout with no resistance levels above the current price. The company's last earnings call, from 30 April 2026, showed Q1 2026 total revenue growth of 15%, organic revenue growth of 11.8%, adjusted EBITDAC up 15.7% to $232 million with margin expansion to 29.2%, and adjusted EPS of $0.47, alongside a $40 million stock repurchase and progress on Ryan Re approaching $2 billion in premium.
The stock closed at $47.11, down 1.3% on the day, sitting above both its 50-day average of $40.82 and 200-day average of $38.86, with one-month returns of 27.3% and six-month returns of 50.6%, though the one-year return stands at -17.3%. The GekkoIndex reads 43.8, placing it in the Distribution zone, down 2.8 over five periods. Price sits 6.3% above Gekko Fair Value of $44.32.
The next earnings date falls on 11 February 2027, 93 days out, placing it beyond a typical 20-trading-day hold. No insider, Congress, or unusual options activity appears in the current windows, and billionaire holders register at zero. Analyst consensus across 12 firms shows 7 buy, 4 hold, and 1 sell ratings, with a consensus target of $49.66, implying 5.4% upside. Seasonality over five years shows an average 20-day return of -1.3% from this point in the calendar, with gains in 3 of those years, worth noting given the current gap to fair value.
Written by AI from the Nov 9, 2026 close and checked automatically against the figures on this page.
Ryan Specialty scores 2 supportive, 2 mixed and 1 headwind across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
2 supportive2 mixed1 headwind
Above 50 and 200-day
Close $46.89 is above the 50-day ($41.18) and 200-day ($38.83) averages, and the 50-day is above the 200-day.
See the chart49.8, Neutral
Reading 49.8 is in the Neutral zone.
See the GekkoIndex6.0% above
Price is 6% above Gekko Fair Value (more than 5% above).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 88 days
Next report Feb 11, 2027, 88 days away — outside a typical 20-trading-day hold.
See earnings+2.9% on average
From this point in the calendar, the next 20 trading days averaged +2.9% over 5 years, rising in 1 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Ryan Specialty closed at $46.89 on Nov 13, 2026, −18.1% over the past year, inside a 52-week range of $29.28 to $58.91.
Use the left and right arrow keys to read daily values.
Put RYAN on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Ryan Specialty works with insurance brokers, agents, and carriers, giving them access to specialized coverage and the support needed to bring it to market. Its offerings cover distribution, underwriting, product creation, administrative handling, and risk management, and the firm is particularly known for acting both as a wholesale broker and as a managing underwriter.
These two roles form the backbone of how the company operates: placing specialized policies on behalf of brokers and agents while also taking on underwriting responsibilities for carriers. The people and firms it serves are insurance brokers, agents, and carriers who turn to it for this combination of distribution and underwriting support rather than a single isolated service.
Founded in 2010, Ryan Specialty is based in Chicago, Illinois. Its stock trades on the NYSE under the ticker RYAN.
Ryan Specialty’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 49.8, in the Neutral zone, up 7.9 points over five sessions.
Up 7.9 points over five sessions, from the Distribution zone.
Reading for Nov 13, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 51 | +0.7% | +3.0% | ||
| Accumulation | 235 | −0.3% | −1.4% | ||
| Neutral (current zone) | 366 | +0.3% | +1.4% | ||
| Distribution | 46 | +1.1% | −0.3% | ||
| Selling | 4 | Too few readings yet | |||
Average RYAN share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +0.9% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
Ryan Specialty trades 6.0% above Gekko Fair Value of $44.22, so the shares are overvalued on Gekko’s estimate.
Gekko’s own estimate of what Ryan Specialty shares are worth, recalculated every trading day.
$44.22
Gekko Fair Value, Nov 14, 2026
6.0% Overvalued
At the end of Aug 2026 the price was 11.4% below the estimate.
No open-market insider purchases were filed for Ryan Specialty, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for RYAN in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in RYAN were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Ryan Specialty has been buying back its own shares.
From company filings.
0of the funds Gekko tracks hold RYAN.
Ryan Specialty reports on Feb 11, 2027, after the close (88 days away), and beat the EPS estimate in 3 of its last 8 reports.
Feb 11, 2027
Expected after the close, 88 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Apr 30, 2026 | $0.47 est $0.43 | $795.2M est $781.4M | −12.6% |
| Feb 12, 2026 | $0.45 est $0.49 | $751.2M est $777.1M | −10.1% |
| Oct 30, 2025 | $0.47 est $0.47 | $754.6M est $777.4M | +7.7% |
| Jul 31, 2025 | $0.66 est $0.65 | $855.2M est $745.7M | −3.8% |
| May 1, 2025 | $0.39 est $0.39 | $690.2M est $679.8M | +2.1% |
| Feb 20, 2025 | $0.45 est $0.45 | $663.5M est $658.4M | −5.8% |
| Oct 30, 2024 | $0.41 est $0.42 | $604.7M est $602.0M | −5.9% |
| Aug 1, 2024 | $0.58 est $0.56 | $701.9M est $695.6M | +11.3% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Ryan Specialty is $48.78, +4.0% from the last close, from 12 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 12 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Nov 13 | Mizuho Securities | $48 | +2.4% |
| Nov 6 | TD Cowen | $62 | +32.2% |
| Nov 5 | J.P. Morgan | $44 | −6.2% |
| Nov 2 | Wells Fargo | $46 | −1.9% |
| Nov 2 | UBS | $52 | +10.9% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Nov 14, Ryan Specialty averaged +2.9% across the last 5 years, rising in 1 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +4.4% | 4 of 5 |
| Next 10 trading days | +5.0% | 3 of 5 |
| Next 15 trading days | +4.6% | 2 of 5 |
| Next 20 trading days | +2.9% | 1 of 5 |
| Next 30 trading days | +1.0% | 2 of 5 |
For scale, RYAN’s typical 20-trading-day move in either direction is about 5.9%.
Ryan Specialty’s market cap is $5.61B, with a P/E ratio of 57.7 and revenue of $3.20B over the last twelve months.
Coverage of Ryan Specialty this week reads negative: 0 positive, 3 neutral and 4 negative headlines.
Ryan Specialty’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| MRSHMarsh | Neutral | 7.1% above |
| AJGArthur J. Gallagher | Neutral | 4.4% above |
| AONAon | Neutral | 3.9% above |
| WTWWillis Towers Watson | Neutral | 0.7% below |
| BROBrown & Brown | Neutral | 2.7% above |
| CRVLCorVel | Neutral | 10.4% above |
A peer links to its own page where one exists.
Ryan Specialty’s market cap is $5.61B at the Nov 13, 2026 close of $46.89, with 119.7M shares outstanding. The shares trade on a P/E ratio of 57.7.
The consensus analyst 12-month price target for Ryan Specialty is $48.78, +4.0% from the last close. Of the 12 firms that rated the stock in the last 90 days, 7 rate it a buy, 4 a hold and 1 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Ryan Specialty is overvalued: the Nov 13, 2026 close of $46.89 is 6.0% above Gekko Fair Value of $44.22. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Ryan Specialty is expected to report on Feb 11, 2027, after the market closes (88 days away). Analysts expect earnings of $0.46 per share on revenue of $785.1M. Ryan Specialty beat the earnings estimate in 3 of its last 8 reports, moving 7.4% on average across the report.
Ryan Specialty’s 52-week high is $58.91 and its 52-week low is $29.28; it closed at $46.89 on Nov 13, 2026, −18.1% over the past year. Over the last five years the shares peaked at $77.16 on Apr 3, 2025.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 5 items with data read as supportive (trend and earnings risk), 2 as mixed (gekkoindex and seasonality) and 1 as a headwind (fair value). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,475 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.